---
title: "Longshenrongfa Pharmaceutical Industry: The holding subsidiary has obtained the renewed \"Drug Manufacturing License\""
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258829694.md"
description: "Longshenrongfa Pharmaceutical Industry announced that its holding subsidiary, Gansu Puan Pharmaceutical Co., Ltd., has completed the renewal procedures for the \"Drug Production License\" due to the application for the reduction of entrusted production related matters. On September 25, 2025, it received the renewed \"Drug Production License\" approved by the Gansu Provincial Drug Administration. The change in this \"Drug Production License\" is mainly due to Puan Pharmaceutical's application for the reduction of the entrusted production of the Xuanfei Zhike Decoction, and the change procedures have been completed in accordance with the law, which will not have a significant impact on production and operations"
datetime: "2025-09-25T08:36:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258829694.md)
  - [en](https://longbridge.com/en/news/258829694.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258829694.md)
generator: "portal-rs"
---

# Longshenrongfa Pharmaceutical Industry: The holding subsidiary has obtained the renewed "Drug Manufacturing License"

Longshenrongfa Pharmaceutical Industry announced that its holding subsidiary, Gansu Puan Pharmaceutical Co., Ltd., has completed the renewal procedures for the "Drug Manufacturing License" due to the application for the reduction of entrusted production related matters. On September 25, 2025, it received the renewed "Drug Manufacturing License" approved by the Gansu Provincial Drug Administration. The change in this "Drug Manufacturing License" is mainly due to Puan Pharmaceutical's application for the reduction of the entrusted production of the Xuanfei Zhike Decoction and has completed the change procedures in accordance with the law, which will not have a significant impact on production and operations

### Related Stocks

- [300534.CN](https://longbridge.com/en/quote/300534.CN.md)

## Related News & Research

- [Cupid share price in focus on board approval to set up manufacturing venture in South African](https://longbridge.com/en/news/297455298.md)
- [SF Holding Reports Solid First Half 2026 Results, Accelerating International Growth and Enhancing Shareholder Returns](https://longbridge.com/en/news/297341511.md)
- [ZOMD: Sequential revenue growth, positive EBITDA, and new clients drive improved outlook](https://longbridge.com/en/news/297530296.md)
- [21:36 ETSpoločnosť XCMG predstavuje prvý 14 000-tonový kruhový žeriav na svete, ktorý nanovo definuje zdvíhanie ultraťažkých bremien](https://longbridge.com/en/news/297378440.md)
- [China Longyuan Power agrees to buy Henan Kunwu 100-MW wind project for RMB 148.64 million](https://longbridge.com/en/news/297201936.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**